hashimoto disease and semaglutide Hypothyroidism: Safety Guide GLP-1 Medications and Autoimmune Thyroid

Understanding how tirzepatide's gastrointestinal side effect profile compares to other incretin-based therapies helps contextualize patient experiences and may inform treatment selection

At the three month mark of oral Wegovy, clinical trial participants lost nearly 6% of their body weight

In: Sorenson J., editor

Just a few weeks after a Super Bowl commercial for a company that sells compounded GLP-1 anti-obesity medications ignited controversy, the Food and Drug Administration (FDA) has determined that the shortage of semaglutide (Ozempic, Wegovy and Rybelsus) is over

So with both helping clients achieve their weight goals, We have created a package combining both Semaglutide injections and Laser Lipo treatments to get you the results you have been dreaming of